Expression of the Human Milk Protein, Beta-Casein : in Transgenic Potato Plants by Roberts, Wendy
Loma Linda University 
TheScholarsRepository@LLU: Digital Archive of Research, 
Scholarship & Creative Works 
Loma Linda University Electronic Theses, Dissertations & Projects 
6-1996 
Expression of the Human Milk Protein, Beta-Casein : in Transgenic 
Potato Plants 
Wendy Roberts 
Follow this and additional works at: https://scholarsrepository.llu.edu/etd 
 Part of the Microbiology Commons, and the Molecular Genetics Commons 
Recommended Citation 
Roberts, Wendy, "Expression of the Human Milk Protein, Beta-Casein : in Transgenic Potato Plants" 
(1996). Loma Linda University Electronic Theses, Dissertations & Projects. 762. 
https://scholarsrepository.llu.edu/etd/762 
This Dissertation is brought to you for free and open access by TheScholarsRepository@LLU: Digital Archive of 
Research, Scholarship & Creative Works. It has been accepted for inclusion in Loma Linda University Electronic 
Theses, Dissertations & Projects by an authorized administrator of TheScholarsRepository@LLU: Digital Archive of 
Research, Scholarship & Creative Works. For more information, please contact scholarsrepository@llu.edu. 
ABSTRACT
EXPRESSION OF THE HUMAN MILK PROTEIN,
BETA-CASEIN, IN TRANSGENIC POTATO PLANTS
by
Wendy Roberts
Mother’s milk is recommended by the nutritional and pediatric communities as the
best food for suckling infants. For non breast-fed infants, bovine milk-based formulas
have been regarded as a suitable substitute. In the early 1900's, physicians found that
foreign proteins in cow milk were responsible for gastrointestinal disease and even
digestive collapse of the newborn fed a cow milk-based diet16. The allergenicity of
cow milk for the human infant appears to be caused predominantly by p-casein17. In
this research, the cDNA encoding human p-casein was introduced into potato cells
under the control of the bidirectional, auxin-inducible mannopine synthase gene
(mas) promoter by Agrobacterium turnefaciens-mediated leaf disc transformation
methods. The presence of the p-casein gene and its transcript in regenerated
transgenic plants were confirmed by PCR and RT-PCR analysis respectively. Human
p-casein protein was detected in leaves of transgenic plants by immunoblot analysis.
The p-casein protein produced by the plants migrated as a single band with a
molecular mass of about 30 KDa and was approximately 0.01% of the total soluble
protein in transgenic potato tissue.
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INTRODUCTION
Human milk contains 0.9% protein (9.0 gm/li)1, of which the casein fraction comprises
30-35% (3.0-3.5 gm/li)2. Human casein consists of three subclasses, ocsl, p-and K-caseinla.
The p-casein is the most abundant (>80%) while a and K-casein account for only a small
proportion of casein content3. Native p-casein is a 25 KDa protein which exists in several
isoforms based on different levels of phosphorylation4,5. In vivo, from 0-5 phosphates are
attached to serine and threonine residues within the first 10 amino acids of the N-terminal
end of the peptide chain4. The phosphorylated seryl and threonryl residues facilitate
p-casein binding of divalent metal ions such as Ca2+, Zn2+, Mn2+ and Fe2+ 5’6. The binding
of Ca2+ to the phosphates in the caseins aids the formation of large casein aggregates
which are prevented from precipitating by K-casein7. Phosphorylation of p-casein is
essential for both assembly of stable micelles and for the behavior of casein as a nutrient.
Human p-casein has both nutritional and physiological benefits for human infants. Like
other milk proteins, such as lactoferrin, IgA and lysozyme, diverse biological effects
have been ascribed to p-casein, or p-casein fragments. These include enhancement of
calcium absorption8,9, inhibition of angiotensin I-converting enzymes10, opiate agonist




Mother’s milk is recommended by the nutritional and pediatric communities as the best
food for suckling infants. For non breast-fed infants, bovine milk-based formulas have
been regarded as a suitable substitute. However, human milk is markedly different from
bovine milk in protein amount and composition. In addition, the amino acid composition
of human and bovine caseins is substantially different. The predominant type of casein in
bovine milk is a-casein which is almost absent in human milk14. The major subclass of
casein in human milk is p-casein which has only 47% sequence homology to bovine
p-casein15 . In addition there is also a 10-residue shift in amino acid alignment between
bovine and human p-caseins 4. Bovine p-casein is fully phosphorylated (5 phosphates)
and forms large micelles. Human p-casein has a variable phosphorylation pattern within
the first 10 amino acid residues at the N-terminal end and can donate divalent cations
more easily. It also forms smaller and softer micellular curds which are considered to be
easier to digest1-2.
In the early 1900's, physicians found that foreign proteins in cow milk were responsible
for gastrointestinal disease and even digestive collapse of the newborn fed a cow
milk-based diet16. The allergenicity of cow milk for the human infant appears to be
caused predominantly by p-casein17. The sensitivity of infants to bovine casein is
extraordinary. Reports of anaphylactic shock from the breast milk of mothers who drink
cow milk are not uncommon18. Differences in amino acid sequence are considered to be
the source of allergy in infants15. Despite the obvious immunological problems with cow
milk and cow milk-based formulas, they have become the primary source of infant
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nutrition in the Western world due to their availability and convenience. Although
breast-feeding may be the best way to provide newborns the benefits and protection of
human nutrition, it is not always physiologically possible or culturally permissible. To
construct plant-based infant formulas which resemble the nutrition of human mother’s
milk, we describe the transformation of potato {Solarium tuberosum) with cDNA
encoding the human P-casein. The plant-produced p-casein is identical in amino acid
sequence to the human p-casein and it can be used in infant formulas to avoid the
immunological and physiological problems caused by cow milk p-casein. This work is
the successful first step in development of a food plant-based protein source for infant
formulas to provide newborns with the benefits of human mother’s milk.
MATERIALS AND METHODS
Cloning of Hbca cDNA in the plant expression vector. The 1065 bp human p-casein
(Hbca) cDNA subcloned into the Sma I site of cloning vector pGEM-3Z, was provided
by Dr. Ravi Menon, University of Colorado. The Hbca insert was excised from the
vector by Xbal and Sad and ligated into the multiple cloning site of plant expression
vector pPCV701FM4 cut with the same restriction endonucleases to give plasmid
pPCV701FM4-Hbca (Fig. 1). Plant expression vector pPCV701FM4 was constructed by
addition of a multiple cloning site, (Bgl II, Xba I, Sma I, Spe I, Sac I, Srfl, BamH I), to
the BamH I site of pPCV701 LuxFPl19,20. The Hbca cDNA was inserted immediately
downstream of the P2 site of the mannopine synthase (mas) P1, P2 dual promoter. A
bacterial luciferase reporter gene21 was fused to the PI site of the mas promoter. The
expression vector also contains the p-lactamase gene which permits ampicillin selection
in E. coli, and carbenicillin selection in Agrobacterium tumefaciens. The neomycin
phosphotransferase II (NPTII) gene allows selection for transformed plants by conferring
kanamycin resistance.
Plasmid pPCV701FM4-Hbca was introduced into the competent £. coli strain HB101 by
electroporation methods as described by Dower et al. (1987)21a. Plasmid DNA was
isolated from ampicillin resistant (Apr) E. coli colonies using the Qiagen plasmid
miniprep kit. The recombinant plasmid containing the Hbca insert was identified by
restriction endonuclease digestion. The DNA sequence of the Hbca cDNA was verified
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by PRIM™ ready reaction DyeDeoxy™ terminator cycle sequencing (Applied
Biosystems, Inc.) with four primers designed to cover the entire Hbca coding region. The
purified plasmid DNA of pPCV701FM4-Hbca, harboring the correct Hbca cDNA
sequence, was introduced into Agrobacterium tumefaciens strain GV3101 pMP90RK by
electroporation using a Biorad Gene Pulser electroporation apparatus according to the
manufacturer’s instructions. Plasmid DNA from several carbenicillin resistant (Carbr)
colonies was isolated and reintroduced into E. coli HB101 for further confirmation of the
plasmid DNA sequence by restriction mapping since recombination can occur in
Agrobacterium and it is difficult to isolate plasmid DNA from that species. A colony of
A. tumefaciens containing the confirmed plasmid pPCV701FM4-Hbca DNA restriction
map was selected for the plant transformation experiment.
Plant transformation. Leaf explants of Solanum tuberosum cv. Bintje were cocultivated
with A tumefaciens strain GV3101 pMP90RK harboring plasmid pPCV701FM4-Hbca
on plant growth medium containing the plant hormones (0.1 mg/1 naphthalene acetic acid
(NAA) and 1 mg/1 trans zeatin (Sigma)), as well as 100 mg/1 kanamycin to select for the
incoming gene and 400 mg/1 claforan for counter-selection against A. tumefaciens. The
explants were incubated in the light room for 3-4 weeks to permit shoot formation at the
wound surface. The leaf explants containing the best looking (green and friable ) callus
tissue were transferred to the same plant growth medium minus NAA for an additional
2-3 weeks to facilitate shoot formation. The regenerated potato shoots were rooted in the
same plant growth medium without plant growth hormones. Roots appeared on the
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transgenic shoots after 2-3 weeks and the regenerated plants were transferred into soil
and grown to maturity in a greenhouse. The presence of the Hbca gene in transformed
plants was determined using the polymerase chain reaction with a forward primer,
5'-ACCAATACATTACACTAGCATCTG-3', specific for the mas P2 promoter and
reverse primer, 5'-GACTGAGTGCGATATTATGTGTAATAC-3', specific for the
polyadenylation region of the TL DNA gene 7. The expected PCR product is the entire
insert of Hbca cDNA. The presence and approximate copy number of Hbca cDNA is
detected by Southern blot analysis22. Approximately 10 pg of genomic DNA was
digested with BamH I. The DNA fragments were separated by electrophoresis on
0.8% agarose gel, and transferred to a positively charged nylon membrane (Boehringer
Mannheim). Transgenic potato genomic DNA fragments were hybridized with a
DIG-PCR labeled Hbca probe which was synthesized by incorporation of DIG-11-dUTP
during PCR with primers specific for Hbca cDNA (5'-forward primer,
5'-GGTGGATCCTGCTCTTATGAGGGAGACCAT-3', and 3'-reverse primer,
5,-TTAACTTTGAGCTCTTCTTAGAC-3'). The DIG-labeled DNA probe was detected
by incubating the hybridized membrane in the chemiluminescent substrate Lumi-Phos
530 between two sheets of clear acetate (plastic page protectors) for 30 minutes at 37°C
followed by a 10 minute exposure on RX Fuji X-ray film
Analysis of Hbca mRNA. Total RNA from leaves of transformed plants was isolated
using an RNeasy plant kit (Qiagen Inc.). The presence of Hbca messenger RNA was
detected from transgenic plants by reverse transcription and polymerase chain reaction
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(RT-PCR) analysis methods23. The first strand of cDNA was synthesized from the Hbca
mRNA by AMY reverse transcriptase with the 3'-reverse primer
(5'-TTAACTTTGAGCTCTTCTTAGAC-3') of Hbca. The resulting first strand of cDNA
was subsequently used as template for synthesis of the second cDNA strand by PCR with
S'-forward primer (5'-GGTGGATCCTGCTCTTATGAGGGAGACCAT-3'), and
3'-reverse primers of Hbca. The product of the RT-PCR was separated by electrophoresis
on a 1.2% agarose gel. The expected RT-PCR product is the full-length coding region of
the Hbca gene.
Detection of Hbca protein. Total soluble protein was extracted from transgenic potato
leaf and tuber tissue by homogenization with a mortar and pestle on ice in 4°C extraction
buffer containing 50 mM Tris-HCl (pH 7.5), 2 mM EDTA, 0.5 mM EGTA, 1 mM PMSF
and 1% Triton X-100. Approximately 200 mg of leaf tissue was homogenized in 600 ul
of extraction buffer and 200 mg of tuber tissue in 300 ul of extraction buffer. The
homogenates were centrifuged in a GS-15R Beckman table top centrifuge at maximum
speed ( 15,000 xg) for 15 minutes at 4°C. Total soluble protein concentration in the
supernatant was measured using a Bio-Rad Bradford protein assay kit. Approximately
150 fig total protein from each sample was denatured by boiling for 5 minutes in sample
loading buffer. The boiled samples were separated on 12 % SDS-PAGE gel, and the
protein bands were electroblotted onto a PVDF membrane. The damp membrane was
blocked with 1% BSA and 20% fetal calf serum in TEST buffer (10 mM Tris-HCl
pH 8.0, 150 mM NaCl and 0.05% Tween 20) for at least 1 hour. The blocked membrane
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was incubated for 1 hour in TEST solution containing a 1:750 dilution of rabbit
anti-p-casein, affinity-purified polyclonal antibody. The anti-Hbca primary
antibody/Hbca antigen complex was then conjugated with a secondary antibody by
incubating the membrane in the 1:1000 TEST dilution of a mouse anti-rabbit IgG
alkaline phosphatase conjugate (Sigma A-2556). Following binding of the secondary
antibody the membrane was washed three times in TEST solution. Colormetric detection
of the recombinant protein was accomplished by incubating the membrane in BCIP/NBT
(5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium) substrate solution.
RESULTS
Plasmid construction: To increase the number of multiple cloning sites and the addition
of a rare cut restriction endonuclease Srf\ for PCR cloning, a poly linker (Bgl II, Xba I,
Sma I, Spe I, Sac I, Srf\, BamH) was added to the plant expression vector
pPCVVOlLux FM120 to give plasmid vector pPCV701LuxFM4. Two partially
complementary oligonucleotides of the polylinker DNA sequences were synthesized with
the 394DNA/RNA synthesizer (Applied Biosystem Inc.). After phosphorylation and
annealing, the double stranded synthetic polylinker was ligated into the BamH I cut and
dephosphorylated pPCV701FMl vector. In order to have one BamH I site in the multiple
cloning site, the polylinker was designed to have Bgl II at one end, thereby preserving
one of the BamH I sites during ligation. The plasmid pPCV701FM4-Hbca was
constructed by inserting the Hbca cDNA into the multiple cloning site of the
pPCV701FM4 between AJa I and Sac I. In this construct, the Hbca gene is placed under
transcriptional control of the mas P2 promoter24. The bacterial luciferase transcriptional
fusion gene21 is driven by the PI site of the mas PI, P2 dual promoter. The bacterial
luciferase transcriptional fusion gene is used as a reporter gene for the screening of
transgenic plants by low-light video image analysis25,26. The construct
pPCV701FM4-Hbca also contains the neomycin phosphotransferase II (NPTII) gene for
selection of transformed plants in kanamycin-containing growth medium.
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Plant cell transformation: Potato leaf explants (S. tuberosum cv Bintje) were
transformed by A. tumerfaciens-med'wted transformation methods. Leaf discs were
infected by A. tumerfaciens, strain GV3101 pMP90RK, harboring the construct
pPCV701FM4-Hbca and cultured in selective medium. The kanamycin resistant putative
transformants were screened for the presence of detectable marker gene by low-light
video image analysis. Six independent potato transformants were obtained which were
resistant to kanamycin and had strong light emission in comparison with the uninfected
control plants. In addition to potato, transformation of N. tobacco cv Samsun with the
construct pPCV701FM-Hbca was also attempted. Ten kanamycin resistant tobacco plants
were regenerated. Eight of the ten plants exhibited bioluminescence detected by low light
video image analysis. However, due to the emphasis on nutrition, further analyses of
Hbca gene expression were carried out on transgenic potato plants.
Detection of Hbca DNA in potato transformants: The presence of Hbca cDNA in the
genomic DNA isolated from regenerated potato transformants was detected by PCR
amplification of Hbca inserts with 5' and 3' flanking primers. The expected PCR product
is a 1314 bp fragment which contains the full length Hbca cDNA plus 5' and 3' regions
flanking the primers. This DNA fragment was detected in all six transgenic potato plants
(Fig.2A, lane 4-9) and no DNA product was detected from the untransformed control
plant DNA (Fig2A, lane 3). The same fragment was amplified using plasmid
pPCV701FM4-Hbca as template (Fig.2A, lanel). The PCR-generated Hbca fragment
was further confirmed by restriction endonuclease mapping. Based on DNA sequence
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analysis, the enzyme Bgl II cuts the Hbca cDNA once and produces two fragments from
PCR-generated product with molecular size of 769 bp and 545 bp, respectively. These
two fragments were produced from the Bgl II digestion of all six lines of transgenic
potatoes (Fig. 2B, lane 2-7). From 1 to 3 copies of Hbca gene were detected in the six
transgenic potato plants by Southern hybridization methods (data not shown).
The presence of Hbca mRNA was detected in leaf tissue of all six transgenic potato
plants using RT-PCR methods. In the reverse transcription reaction, a 3' reverse primer
from the region right after the stop codon of Hbca cDNA was designed to synthesize the
first Hbca cDNA strand. In combination with a 5' forward primer which is located in the
front of the Hbca gene start codon, the full length coding region of the Hbca gene was
amplified directly from the reaction mixture of RT from all six transgenic potato plants
(Fig. 3, lane 3- 8). No RT- PCR product was observed from RNA isolated from
untransformed potato plants (Fig. 3. lane 2). The Hbca DNA fragment was amplified
when pPCV701FM4-Hbca plasmid DNA was used as the template (Fig. 3, lane 1). To
eliminate the possibility of DNA contamination in the plant total RNA preparation, the
RNA sample was used as a template for PCR. No amplified DNA products were detected
(data not shown)
Human p-casein Protein Expression. Recombinant p-casein protein was detected in
leaf tissue homogenates by immunoblot methods using an affinity-purified rabbit
polyclonal antibody specific for human P-casein. During electrophoresis, the
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plant-produced p-casein migrated as a single band in the SDS-PAGE gel with a
molecular weight of approximately 30 KDa, which was about 1 KDa smaller than the
phosphorylated human p-casein 2P isoform (Fig. 4, lane 5, 7, 9 and 11). No protein band
was observed in untransformed control plant homogenates (Fig. 4, lane 3). In
pPCV701FM4-Hbca, the mannopine synthase dual promoters are regulated
predominantly by the plant growth hormone auxin 26. In addition, the mas promoter
acitivity can be further induced by wounding the plant leaf or tuber tissue 24-48 hours
prior to assay. The mas promoter activity in uninduced transgenic plant tissues is barely
detectable. In this experiment, uninduced tissue samples of the transgenic plants did not
show an immuno-staining band at the molecular weight of the Hbca protein (Fig. 4,
lane 4, 6, 8, and 10) as compared with the wounded and auxin induced leaf samples of
the same plants (Fig.4, lane 5, 7, 9, 11). No corresponding band was detected in either
induced or uninduced leaf tissue samples from untransformed plants (Fig. 4, lane 2,3). In
comparison with pure human p-casein 2P standard on immunoblots, the amount of
recombinant P-casein in wounded and auxin-induced leaf tissue was estimated to be
approximately 105 pg P-casein per gram of soluble potato protein. This value represents
approximately 0.01% of total soluble potato plant protein. The expression of Hbca in
potato tuber tissue determined by immunoblot analysis was unexpectedly low in
comparison to luciferase enzyme activity detected by a bioluminescence assay. There
was a barely visible antibody-reacting band in tubers of transgenic plants in response to
auxin induction. However, p-casein was detected in potato tuber slices after five-day
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auxin induction by immunoprecipitation and phosphoprotein preparation methods (data
not shown).
DISCUSSION AND CONCLUSIONS
We have engineered transgenic S. tuberosum cv Bintje potato plants to express the
human gene encoding p-casein, a major human milk protein. The recombinant protein
was detected by immunoblot analysis in both leaf and tuber tissue using an
affinity-purified polyclonal antibody specific for human p-casein. The Hbca gene
product was detected from the total soluble protein extract of the leaf. However, the
expression of this gene in auxin-stimulated, wounded tuber tissue was detected after
immunoprecipitation. In the construct of pPCV701FM4-Hbca, the human p-casein gene
is driven by the mas P2 promoter. We have observed a similar result in S. tuberosum
potato plants transformed with human insulin gene under the control of the mas P2
promoter. This suggests that the mas P2 promoter may be less active in tubers than in
leaf tissue. This experimental result is in apparent contradiction to the generally held
perception based on luciferase gene product activity, which is that the mas P2 promoter
is more strongly expressed in tuber than in leaf tissue. Based on light emission
measurements, the activity of the reporter bacterial luciferase enzyme coded for by the
luciferase fusion gene (Lux F) under the control of the mas PI promoter is about 5 times
higher in tuber than in leaf tissue. Therefore, the possibility of proteolytic degradation of
p-casein protein in tuber tissue can not be excluded. Degradation of human p-casein was
27.observed in insect cell culture when expressed in recombinant Baculovirus systems
14
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Based on the results of immunoblot experiments, the plant-produced p-casein protein
appears in a single form with molecular mass of about 1 KDa less than the purified
human phosphorylated p-casein 2P isoform (Fig. 4). Since the full length mRNA was
detected by RT-PCR (Fig. 3), the smaller size of the plant p-casein protein may be due to
differences in post-translational modifications between plant and animal cells,
i.e. possibly glycosylation or phosphorylation. Complex glycans in plants are often
smaller than those found in animals in part due to the absence of sialic acid28. Human
p-casein is phosphorylated at the N-terminal end of the peptide. Depending on the
phosphorylation state, from 0-5 phosphates can be attached to serine and threonine
residues within the first 10 amino acids of the N-terminal end of the protein. We have
attempted to isolate phosphoproteins from transgenic leaf protein homogenate. The
phosphoprotein fraction was precipitated from total protein extracts by glacial acetic acid
and ethanol at pH 4.6. A protein band of identical mobility to p-casein from human milk
was observed on immonoblots from the phosphoprotein sample and from the total protein
extract (data not shown). This result suggests that plant-produced P-casein may be
phosphorylated, although the molecular mass may be slightly smaller than the
phosphorylated p-casein from human milk. Immuno-affinity column purification
experiments are presently in progress to isolate larger amounts of p-casein from
transgenic plants. These experiments, we hope, will provide enough p-casein to permit
N-terminal amino acid analysis to establish the N-terminal amino acid composition of
plant-produced p-casein. Calcium binding experiments will permit us to determine the
16
micellular aggregation patterns of plant-synthesized p-casein and its differences in
structure in comparison to p-casein from human milk.
To determine the maximum amount of human p-casein produced in transgenic potato, we
are regenerating callus tissue from transformed leaf and tuber tissue. Analysis of the
callus tissue may promote an increase up to 0.5% of the total protein as demonstrated in
recent experiments in our lab, calculated from transgenic potato plant callus producing
cholera B toxin protein (experiments not presented). The amount of p-casein produced in
transgenic plants driven by the mas P2 promoter is approximately 0.01% of the total
soluble protein. Additional experiments on cloning and expression of Hbca under the
control of the cauliflower mosaic virus 35S promoter and the potato patatin promoter, to
obtain higher levels of p-casein expression in transgenic plants, are in progress in our
laboratory. The patatin promoter has been demonstrated to produce up to 10% of total
patatin synthesis as recombinant protein (J. Spychalla personal comm). Since patatin
produces approximately 20% of total soluble protein, human p-casein amounts could be
as high as 2% of total soluble potato protein. Thus it may be possible to obtain higher
levels of expression than presently seen in potato tubers. According to the
U S. Department of Commerce and the USDA estimates, the average production of
potatoes in the USA in 1995 was 33,400 pounds per acre. If total soluble potato tuber
protein is estimated as 23 mg per gram of green fresh weight (personal communication),
at a level of 2% of recombinant p-casein expression, driven by patatin promoter, an
estimated 1.2 kilogram casein can be produced per acre of potato plantation. If there is
17
approximately of 0.9 gram p-casein per liter of human milk28, the amount of p-casein
produced per acre of potatoes equals approximately that in 1333 liters of human milk. It
can be seen from the above estimates that p-casein can be efficiently produced in
transgenic food plants. This work opens the way for production of additional human milk
proteins such as lactoferrin, lysozyme and a-lactalbumin in food plants which can
ultimately lead to development of high quality infant formulas and baby foods with
maximal nutritional potential and protection of newborns against the development of
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Figure 1. Structure of the plant expression vector pPCV701FM4-Hbca. The recombinant 
plasmid carries the left and right 25 bp direct repeat borders (LB and RB) of the 
transferred DNA (T-DNA) that demarcates the region that is incorporated into plant 
genome via Agrobacterium-mQ&\ditQ& transformation. Human p-casein cDNA is placed 
downstream of the P2 promoter of the mannopine synthase gene (mas) and is followed 
by the polyadenylation sequences of the TL-DNA gene 7 (g7pA). The bacterial luciferase 
fusion gene (Lux F) is driven by the mas PI promoter and is terminated by the 
polyadenylation sequences of the octopine synthase gene (OcspA). Arrows indicate the 
direction of transcription. Restriction endonuclease cleavage sites are indicated.
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Detection of Human G casein cDNA in Potato Tissues








Figure 2. Lanes in the left panel represent PCR amplification of the Hbca gene from leaf tissue of transgenic potato plants. Lane M, 1 kb 
DNA ladder. Lane 1, plasmid pPCVFM4-Hbca control, lane 2, H20 control, lane 3, untransformed plant control, lane 5-9 are individual 
transgenic potato plants. Lanes in the right panel represent The enzyme Bgl II digestion of the PCR generated fragments. Lane M, OF 174 
RF Hae III fragments. Lane 1, plasmid control; lane 2-7 are individual transgenic potato plants. Arrows indicate the PCR products (left 
panel) and Bgl II digestion fragments of the PCR products (right panel).
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Figure 3. RT-PCR analysis of Hbca RNA in transgenic potato plants. Lane 1, plasmid 
pPCVFM4-Hbca control; lane 2, untransformed plant control; lane 3-8, six transgenic 
potato lines and lane M, OF 174 RF Hae III fragments. Arrow indicates the position of 
RT-PCR product.
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Figure 4. Immunodetection of p-casein protein from leaf extract of the transgenic potato plants. Total soluble protein extract from potato 
leaves was fractionated by SDS-PAGE, blotted onto a PVDF membrane, and probed with a rabbit anti-p-casein polyclonal antibody.
Lane 1, pure human p-casein isolated from human milk. The remaining lanes contain protein isolated from leaf tissue in which the mas 
promoters were either not induced or induced by incubation on culture medium containing auxin (10'4M). Lane 2 and 3, untransformed 
plant; lane 4, 6, 8, and 10, the uninduced leaf tissue from four selected transgenic plants; lane 5, 7, 9, and 11 show the induced leaf tissue 
from the four selected transgenic plants.
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